Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Multivariate analysis for overall survival in metastatic gastric cancer patients (n = 123)

From: Identification of prognostic factors and surgical indications for metastatic gastric cancer

Variable HR 95% CI p value
PS 3 8.69 3.45–21.87 < 0.001
NLR >3.1 2.30 1.44– 3.67 < 0.001
CA19-9 > 37 U/mL 1.77 1.14–2.76 0.012
Bulky lymph nodes 1.53 0.98–2.39 0.063
Gastrectomy with or without metastasectomy 0.55 0.32–0.95 0.033